![]() |
市场调查报告书
商品编码
1383424
2030 年机器人义肢市场预测:按技术、肢体、最终用户和地区进行的全球分析Robotic Prosthetics Market Forecasts to 2030 - Global Analysis By Technology (Microprocessor-Controlled Prosthetics, Myoelectric Prostheses, Machine Learning and Other Technologies), By Extremity, End User and By Geography |
根据Stratistics MRC预测,2023年全球机器人义肢市场规模将达15亿美元,预计2030年将达到31亿美元,预测期内年复合成长率为10.8%。
机器人义肢,也称为仿生义肢,是指医疗技术和动态工程领域,涉及设计、开发和实施配备义肢技术和先进感测器技术的义肢或义肢。这些机器人义肢旨在替换或增强缺失或无功能的身体部位(通常是手臂、手、腿、脚等)。
据截肢者联盟称,美国有超过 200 万人失去肢体,其中大多数(54%)是由于糖尿病和周边动脉疾病疾病造成的,45% 是由于外伤造成的。
全球截肢人口的增加是机器人义肢市场的关键驱动因素。事故、医疗状况和高龄化等因素导致截肢者数量增加。因此,对先进的义肢和矫正器具解决方案的需求不断增长,以改善这些人的活动能力和生活品质。机器人义肢提供增强的功能、自然的运动和矫正器具的用户体验,使其成为一个有吸引力的选择。这种不断增长的需求将推动市场创新和投资,进一步扩大世界各地截肢者的覆盖范围和可及性。
由于这些先进医疗设备的成本高昂,保险范围往往有限,使得许多人在经济上无法获得它们。此外,许多保险公司不承担全部医疗费用,这给患者带来了经济负担。此外,认证和合规要求等法规障碍可能导致製造延迟和成本增加,从而阻碍市场成长。
人工智慧、先进材料和感测器系统矫正器具最尖端科技正在推动更复杂、更实用的义肢的开发。这些创新提高了使用者的行动能力、反应能力和舒适度。此外,3D 列印和客製化可实现客製化解决方案,远端医疗和远端监控可改善患者照护。该技术还有可能提高成本效率并使这些设备更便宜。总体而言,持续的技术进步正在扩大可能性,提高截肢者的生活质量,并扩大机器人义肢市场的范围。
在矫正器具地区,可得性有限,限制了先进义肢和矫正器具技术的取得。在基础设施、医疗保健设施不足和经济困难的地区,患者可能很难获得或购买这些改善生活的设备。这种获取机会的不平等导致截肢者的医疗结果差异,生活品质下降,阻碍了市场成长。
COVID-19 的爆发对市场产生了多方面的影响。供应链中断和製造延误给生产和分销带来了挑战。然而,这场大流行凸显了远端监控和远端医疗解决方案的重要性,推动了义肢矫正器具和患者照护的创新。儘管获得医疗服务的机会有限,但对远距復健和远距调整等先进义肢和矫正器具义肢的需求却激增。在疫情大流行后,人们可能会重新关注改善可近性、与远端医疗的整合以及弹性供应链,以更好地为需要机器人义肢的患者提供服务。
从市场区隔来看,上半身义肢预计将占据最大的市场占有率。上半身义肢,例如机械臂和机械手,为上肢缺陷或肢体残疾的人提供了显着的功能改善。这些对于抓取、操作和日常生活等任务至关重要,并有助于不断增长的需求。此外,上半身机器人义肢和矫正器具的进步使得控制系统变得更加复杂和直观,使它们对截肢者越来越有吸引力,从而推动了细分市场的扩张。
在市场上,医院和诊所领域预计将显着成长。医院和诊所是医疗干预和患者照护的重要中心,使其成为采用和提供机器人义肢解决方案的天然中心。此外,随着这项技术变得更加先进和易于使用,医疗专业人员越来越多地将机器人义肢纳入治疗方案中。此外,医院和诊所正在提供专门的机器人义肢服务,以扩大使用范围并改善患者的治疗效果,从而推动市场的显着成长。
北美预计将主导市场的主要原因包括先进的医疗基础设施、高水准的医疗费用以及领先的矫正器具和义肢製造商和研究机构的强大实力。此外,相对较高的肢体缺陷盛行率和人口高龄化增加了对先进义肢解决方案的需求。此外,有利的报销政策和积极引进创新医疗技术的做法进一步提高了北美在机器人领域的市场占有率。
由于高龄化和义肢缺陷数量的增加推动了对先进义肢和矫正器具解决方案的需求,预计亚太地区将呈现最高的市场成长率。在中国、日本和韩国等国家,技术进步和医疗保健投资的增加正在推动创新。此外,政府的支持措施以及医疗保健提供者和科技公司之间的合作也进一步支持市场扩张。
According to Stratistics MRC, the Global Robotic Prosthetics Market is accounted for $1.5 billion in 2023 and is expected to reach $3.1 billion by 2030 growing at a CAGR of 10.8% during the forecast period. Robotic prosthetics, also known as bionic prosthetics, refer to the field of medical technology and biomechanical engineering that involves the design, development, and implementation of artificial limbs or prosthetic devices equipped with robotics and advanced sensor technologies. These robotic prosthetic limbs are designed to replace or augment missing or non-functional body parts, typically arms, hands, legs, or feet.
According to the Amputee Coalition, of the more than 2 million people living with a loss of limb in the U.S., majority (54%) were due to diseases like diabetes, peripheral arterial disease etc. and 45% were due to trauma.
The growing global amputee population is a significant driver of the robotic prosthetics market. Factors such as accidents, medical conditions, and an aging population contribute to an increasing number of amputees. As a result, there is a growing demand for advanced prosthetic solutions to improve the mobility and quality of life of these individuals. Robotic prosthetics offer enhanced functionality, natural movement, and an improved user experience, making them a compelling choice. This rising demand fuels innovation and investment in the market, further expanding its reach and accessibility to amputees worldwide.
The high costs associated with these advanced devices often result in limited insurance coverage, making them financially inaccessible for many individuals. Many insurance providers may not fully cover the expenses, placing financial burdens on patients. Additionally, regulatory hurdles, including certification and compliance requirements, can lead to delays and increased manufacturing costs, hindering market growth.
Cutting-edge technologies, such as artificial intelligence, advanced materials, and sensor systems, enable the development of more sophisticated and functional prosthetic devices. These innovations enhance mobility, responsiveness, and comfort for users. Additionally, 3D printing and customization enable tailored solutions, while telehealth and remote monitoring offer improved patient care. Technology also drives cost efficiencies, potentially making these devices more affordable. Overall, ongoing technological advancements are expanding the possibilities, improving the quality of life for amputees, and broadening the reach of the robotic prosthetics market.
The limited availability of robotic prosthetic devices in certain regions restricts access to advanced limb replacement technology. In regions with inadequate infrastructure, healthcare facilities, or economic challenges, patients may struggle to access or afford these life-enhancing devices. This inequality in access can result in disparities in healthcare outcomes and a reduced quality of life for amputees, which hinders the growth of the market.
The COVID-19 pandemic has had a multifaceted impact on the market. Supply chain disruptions and manufacturing delays led to challenges in production and distribution. However, the pandemic underscored the importance of remote monitoring and telehealth solutions, driving innovation in prosthetic control and patient care. While access to healthcare services faced restrictions, the demand for advanced prosthetic solutions, like tele-rehabilitation and remote adjustments, surged. Post-pandemic, the market is likely to see a renewed focus on enhancing accessibility, telehealth integration, and resilient supply chains to better serve patients in need of robotic prosthetics.
The upper-body prosthetics segment is expected to capture the largest market share in the market. Upper-body prosthetics, such as robotic arms and hands, offer significant functional improvements for individuals with upper-limb limb loss or limb disabilities. They are crucial for tasks like grasping, manipulation, and daily activities, contributing to a higher demand. Additionally, advancements in upper-body robotic prosthetics have led to more sophisticated and intuitive control systems, making them increasingly appealing for amputees, which is fostering segment expansion.
The hospitals and clinics segment in the market is positioned for substantial growth. Hospitals and clinics are key centers for medical interventions and patient care, making them natural hubs for the adoption and provision of robotic prosthetic solutions. Moreover, as the technology becomes more advanced and accessible, healthcare professionals are increasingly incorporating robotic prosthetics into their treatment protocols. Additionally, hospitals and clinics offer specialized robotic prosthetic services, expanding access and improving patient outcomes, thus driving significant market growth.
North America is anticipated to dominate the market primarily due to its advanced healthcare infrastructure, high levels of healthcare expenditure, and significant presence of leading prosthetics manufacturers and research institutions. Moreover, a relatively high prevalence of limb loss cases, coupled with a growing aging population, is driving the demand for advanced prosthetic solutions. Additionally, favorable reimbursement policies and a proactive approach towards adopting innovative healthcare technologies further contribute to North America's market share in the robotics sector.
The Asia Pacific region is expected to exhibit the highest growth rate in the market due to the region's rapidly aging population, coupled with an increasing incidence of limb loss, which is driving demand for advanced prosthetic solutions. Technological advancements and rising healthcare investments in countries like China, Japan, and South Korea are fostering innovation. Additionally, supportive government initiatives and collaborations between healthcare providers and technology firms are further propelling market expansion.
Some of the key players in Robotic Prosthetics Market include: Aethon, Asensus Surgical, Endolite India Ltd, Hansen Medical, Inc., HDT Global Inc, Intuitive Surgical, Inc., Mazor Robotics Ltd., Medrobotics Corporation, Open Bionics, Ossur Americas, Ottobock, Re Walk Robotics, Shadow Robot Company, Smith & Nephew, Stryker Corporation, SynTouch, Inc and ZOLL Medical Corporation.
In October 2022, Researchers at the University of Utah's Bionic Engineering Lab have developed the "Utah Bionic Leg," the most advanced bionic leg ever created. Now, the university has forged a new partnership with the worldwide leader in the prosthetics industry, Ottobock, to license the technology behind the Utah Bionic Leg and bring it to individuals with lower-limb amputations.
In February 2022, New York-based engineering startup Esper Bionics has developed a prosthetic arm with intuitive self-learning technology that can predict intended movement faster than similar prosthetics.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.